XML 74 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Revenue:    
Total revenue $ 22,616 $ 22,241
Operating costs and expenses:    
Type of Cost, Good or Service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember
Product costs $ 3,203 $ 3,523
Research and development 12,142 11,486
Selling, general and administrative 6,943 5,949
Acquired intangible asset amortization 594 606
Contingent consideration gain   (35)
Total operating costs and expenses 22,882 21,529
Operating (loss) income (266) 712
Other income:    
Investment income, net 250 316
Interest expense (40) (37)
Foreign exchange (loss) gain (47) 136
Other 1 7
Other income 164 422
(Loss) income before income taxes (102) 1,134
Income tax benefit 250 176
Net income $ 148 $ 1,310
Basic net income per share: $ 0.01 $ 0.10
Diluted net income per share: $ 0.01 $ 0.09
Weighted average number of shares outstanding:    
Basic 13,469 13,367
Diluted 13,769 13,827
Product Sales [Member]    
Revenue:    
Total revenue $ 9,974 $ 9,751
Royalties and License Fees [Member]    
Revenue:    
Total revenue 10,148 10,096
Research, Development and Other [Member]    
Revenue:    
Total revenue $ 2,494 $ 2,394